Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "structural biology"

ResearchPUBMEDMay 12

VUStruct: A compute pipeline for high throughput and personalized structural biology.

Scientists created a new computer tool called VUStruct that helps doctors understand genetic mutations found in patients with rare diseases. Instead of just looking at DNA sequences, this tool examines how mutations affect the actual 3D shape and function of proteins in the body. By combining genetic data with protein structure information and artificial intelligence, VUStruct helps doctors figure out which genetic changes are actually causing disease.

WHY IT MATTERSIf you or a family member has been told they have a genetic variant of unknown significance (VUS), VUStruct could help your doctor determine whether that variant is actually causing your rare disease or if it's harmless.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases